Review for 'Improvement of glycemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 1 study)'
Autor: | null Cheng Cai Tang |
---|---|
Rok vydání: | 2022 |
DOI: | 10.1111/dom.14998/v1/review3 |
Databáze: | OpenAIRE |
Externí odkaz: |